HT
MCRB icon

HAP Trading’s Seres Therapeutics MCRB Stock Holding History

HAP Trading’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$335K Buy
+125,000
New +$1.99M 0.02% 316
2022
Q1 		– Sell
-2,075
Closed -$39K – 2569
2021
Q4 		$39K Buy
+2,075
New +$330K ﹤0.01% 1573
2021
Q2 		– Sell
-565
Closed -$23K – 2560
2021
Q1 		$23K Buy
+565
New +$260K ﹤0.01% 1414
2020
Q4 		– Sell
-7,950
Closed -$252K – 2357
2020
Q3 		$252K Buy
+7,950
New +$2.64M 0.01% 565

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

HAP Trading's MCRB Position: Q4 2021 in Review

HAP Trading sold out of Seres Therapeutics (MCRB) in Q4 2021, closing a stake of 2,002 shares — an estimated $318K sold.

HAP Trading first reported a position in MCRB in Q3 2021 and held it in 1 quarter. The position peaked at $279K in Q3 2021. 148 funds tracked by Wall St. Rank hold MCRB as of Q4 2021.

  • HAP Trading reported no remaining Seres Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 2,002 Seres Therapeutics shares in Q4 2021, an estimated $318K.
  • HAP Trading first reported a position in Seres Therapeutics in Q3 2021 and held it in 1 quarter.
  • HAP Trading's Seres Therapeutics position peaked at $279K in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.